Filing Flows › Amphastar Pharmaceuticals (AMPH) › How it makes money
How Amphastar Pharmaceuticals (AMPH) makes money
Amphastar Pharmaceuticals (AMPH) made $208M of revenue in the third quarter 2026 (Q3 2026), +8% from a year earlier. Of every dollar of revenue, 48¢ was left as gross profit, 24¢ was left as operating profit, 18¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $208M | 100.0% |
| Cost of revenue | $108M | 52.0% |
| Gross profit | $99.6M | 48.0% |
| Operating expenses | $48.9M | 23.5% |
| Operating profit | $50.8M | 24.5% |
| Income tax | $11.3M | 5.4% |
| Net earnings | $37.8M | 18.2% |
| Operating cash flow | $43.3M | 20.9% |
| Free cash flow | $33.4M | 16.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $208M | +8% |
| Q2 2026 | $184M | +5% |
| Q1 2026 | $171M | +0.4% |
| Q4 2025 | $183M | -2% |
| Q3 2025 | $192M | +0.3% |
| Q2 2025 | $174M | -4% |
| Q1 2025 | $171M | -0.8% |
From Amphastar Pharmaceuticals' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Amphastar Pharmaceuticals make money?
Amphastar Pharmaceuticals (AMPH) made $208M of revenue in the third quarter 2026 (Q3 2026), +8% from a year earlier. Of every dollar of revenue, 48¢ was left as gross profit, 24¢ was left as operating profit, 18¢ was left as net earnings.
What is Amphastar Pharmaceuticals' profit margin?
Net earnings were $37.8M, 18.2% of revenue, in the third quarter 2026; the operating margin was 24.5%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.